Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-γ|RISS 상세보기

다국어 초록 (Multilingual Abstract)

The aim of this study was to examine the efficacy of in ovo prime-boost vaccination against infectious bursal disease virus (IBDV) using a DNA vaccine to prime in ovo followed by a killed-vaccine boost post hatching. In addition, the adjuvant effects of plasmid-encoded chicken interleukin-2 and chicken interferon-γ were tested in conjunction with the vaccine. A plasmid DNA vaccine (pcDNA-VP243) encoding the VP2, VP4, and VP3 proteins of the very virulent IBDV (vvIBDV) SH/92 strain was injected into the amniotic sac alone or in combination with a plasmid encoding chicken IL-2 (ChIL-2) or chicken IFN-γ (ChIFN-γ) at embryonation day 18, followed by an intramuscular injection of a commercial killed IBD vaccine at 1 week of age. The chickens were orally challenged with the vvIBDV SH/92 strain at 3 weeks of age and observed for 10 days. In ovo DNA immunization followed by a killedvaccine boost provided significantly better immunity than the other options. No mortality was observed in this group after a challenge with the vvIBDV. The prime-boost strategy was moderately effective against bursal damage, which was measured by the bursa weight/body weight ratio, the presence of IBDV RNA, and the bursal lesion score. In ovo DNA vaccination with no boost did not provide sufficient immunity, and the addition of ChIL-2 or ChIFN-γ did not enhance protective immunity. In the ConA-induced lymphocyte proliferation assay of peripheral blood lymphocyte collected 10 days post-challenge, there was greater proliferation responses in the DNA vaccine plus boost and DNA vaccine with ChIL-2 plus boost groups compared to the other groups. These findings suggest that priming with DNA vaccine and boosting with killed vaccine is an effective strategy for protecting chickens against vvIBDV.

번역하기

참고문헌 (Reference)

1 Murphy FA, "Virus Taxonomy: Sixth Report of the International Committee on Taxonomy of Viruses" Springer-Verlag 240-244, 1995

2 Rautenschlein S, "The role of T cells in protection by an inactivated infectious bursal disease virus vaccine" 89 : 159-167, 2002

3 Ramshaw IA, "The prime-boost strategy: exciting prospects for improved vaccination" 21 : 163-165, 2000

4 Hsieh MK, "The effect of co-administration of DNA carrying chicken interferon-gamma gene on protection of chickens against infectious bursal disease by DNAmediated vaccination" 24 : 6955-6965, 2006

5 Lin Z, "Sequence comparisons of a highly virulent infectious bursal disease virus prevalent in Japan" 37 : 315-323, 1993

6 Lillehoj HS, "Resistance to intestinal coccidiosis following DNA immunization with the cloned 3-1E Eimeria gene plus IL-2, IL-15, and IFN-gamma" 49 : 112-117, 2005

7 Harms JS, "Regulation oftransgene expression in genetic immunization" 32 : 155-162, 1999

8 Yeh HY, "Protective immunity against infectious bursal disease virus in chickens in the absence of virus-specific antibodies" 89 : 149-158, 2002

9 Kapczynski DR, "Protection of chickens from infectious bronchitis by in ovo and intramuscular vaccination with a DNA vaccine expressing the S1 glycoprotein" 47 : 272-285, 2003

10 Mahmood MS, "Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide" 24 : 4838-4846, 2006